Familial adenomatous polyposis

Orphanet Journal of Rare Diseases

Volumn 4, Issue 1, 2009, Pages

  Half, Elizabeth ^a   Bercovich, Dani ^b,c   Rozen, Paul ^d,e  

^a Meir Hospital   (Ireland)

^b Human Molecular Genetics and Pharmacogenetics   (Ireland)

^c TEL HAI COLLEGE   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CELECOXIB; DACARBAZINE; DOXORUBICIN; EFLORNITHINE; ESTROGEN; METHOTREXATE; NAVELBINE; PROGESTERONE; ROFECOXIB; SULINDAC; TAMOXIFEN; VINBLASTINE; VINCRISTINE; WNT1 PROTEIN;

ABDOMINAL PAIN; ADENOMA; ADENOMATOUS POLYP; AMNIOCENTESIS; ANEMIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BILE DUCT; BILE DUCT CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONSTIPATION; CYTOTOXICITY; DESMOID TUMOR; DIARRHEA; DIET; DIFFERENTIAL DIAGNOSIS; DUODENUM CANCER; ENDOSCOPY; EXCISION REPAIR; FAMILIAL CANCER; FAMILIAL DISEASE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GARDNER SYNDROME; GASTROINTESTINAL TUMOR; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; GERM LINE GENE THERAPY; HUMAN; ILEORECTAL ANASTOMOSIS; IMPLANT; JUVENILE POLYP; LEGAL ASPECT; LIFESTYLE; LIVER CANCER; MANDIBLE FRACTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; ODONTOGENIC TUMOR; OSTEOMA; PATIENT REFERRAL; PEUTZ JEGHERS SYNDROME; PHENOTYPE; PIGMENT EPITHELIUM; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PREVALENCE; PROCTOCOLECTOMY; PROGNOSIS; PROPHYLAXIS; PROTEIN FUNCTION; QUALITY OF LIFE; RECTUM HEMORRHAGE; RELATIVE; SCREENING; SHOULDER; SKULL INJURY; SOCIAL ASPECT; SYMPTOM; THYROID CANCER; TREATMENT RESPONSE; TUMOR GROWTH; WEIGHT REDUCTION; ANIMAL; COLON POLYPOSIS; FEMALE; MALE; METABOLISM; PATHOLOGY; REVIEW;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; FEMALE; HUMANS; MALE;

EID: 72449167940     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-4-22     Document Type: Article

References (114)

1. A genetic study of multiple polyposis of the colon with an appendix deriving a method of estimating relative fitness. TE Reed JV Neel, Am J Hum Genet 1955 7 236 263 13258558
2. Surgical treatment of hereditary adenomatosis of the colon and rectum in Sweden during the last 20 years. Part II. Patients with prophylactic operations, primary and late results. Discussion and summary. T Alm, Acta Chir Scand 1975 141 228 237 1166747
3. European Medicines Agency Doc. Ref.:EMEA/COMP/264/04draft. http://www.emea.europa.eu/pdfs/human/comp/opinion/026404en.pdf
4. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. GM Petersen J Slack Y Nakamura, Gastroenterology 1991 100 1658 1664 1673441
5. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. KL Bianch CA Buerke AE Bennett R Lopez H Hasson JM Church, Clin Gastroenterol Heptatol 2008 6 180 185 10.1016/j.cgh.2007.11.018 (Pubitemid 351172948)
6. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. SC Abraham B Nobukawa FM Giardiello SR Hamilton TT Wu, Am J Pathol 2000 157 747 754 10980114
7. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. AD Spigelman CB Williams IC Talbot P Domizio RK Phillips, Lancet 1989 2 783 785 10.1016/S0140-6736(89)90840-4 2571019
8. Duodenal adenomatosis in familial adenomatous polyposis. S Bülow J Björk IJ Christensen O Fausa H Järvinen F Moesgaard HF Vasen DAF Study Group, Gut 2004 53 381 386 10.1136/gut.2003.027771 14960520
9. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. I Heiskanen I Kellokumpu H Järvinen, Endoscopy 1999 31 412 416 10.1055/s-1999-41 10494676
10. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. CJ Groves BP Saunders AD Spigelman RK Phillips, Gut 2002 50 636 641 10.1136/gut.50.5.636 11950808
11. Familial Adenomatous Polyposis. S Bülow, Ann Med 1989 21 299 307 10.3109/07853898909149211 2551351
12. Duodenal Adenomatosis in Familial Adenomatous Polyposis. S Bülow J Björk IJ Christensen O Fausa H Järvinen F Moesgaard HF Vasen DAF Study Group, Gut 2004 53 381 386 10.1136/gut.2003.027771 14960520
13. Jejunal polyps in familial adenomatous polyposis assessed by push-type endoscopy. G Bertoni R Sassatelli P Tansini E Ricci R Conigliaro G Bedogni, J Clin Gastroenterol 1993 17 343 347 10.1097/00004836-199312000-00016 8308223
14. Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy. T Matsumoto M Esaki R Yanaru-Fujisawa T Moriyama S Yada S Nakamura T Yao M Iida, Gastrointest Endosc 2008 68 911 919 10.1016/j.gie.2008.02.067 18561922
15. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. G Iaquinto M Fornasarig M Quaia N Giardullo D'Onofrio S Iaquinto S Di Bella R Cannizzaro, Gastrointest Endosc 2008 67 61 67 10.1016/j.gie.2007.07.048 18155426
16. The utility of capsule endoscopy small bowel surveillance in patients with polyposis. CA Burke J Santisi J Church G Levinthal, Am J Gastroenterol 2005 100 1498 1502 10.1111/j.1572-0241.2005.41506.x 15984971
17. The history of Familial Adenomatous Polyposis. S Bülow T Berk K Neale, Fam Cancer 2006 5 213 220 10.1007/s10689-005-5854-0 16998666
18. A genetic study of Gardner syndrome and congenital hypertrophy of the retinal pigment epithelium. LA Lyons RA Lewis LC Strong S Zuckerbrod RE Ferrell, Am J Hum Genet 1988 42 290 296 3422541
19. Adenocarcinoma arising from congenital hypertrophy of retinal pigment epithelium. JA Shields CL Shields RC Eagle Jr AD Singh, Arch Ophthalmol 2001 119 597 602 11296028
20. Current ideas in desmoid tumors. NJ Sturt SK Clark, Fam Cancer 2006 5 275 285 10.1007/s10689-005-5675-1 16998673
21. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. J Turcot J-P Després F St Pierre, Dis Colon Rectum 1959 2 465 468 10.1007/BF02616938 13839882
22. The molecular basis of Turcot's syndrome. SR Hamilton B Liu RE Parsons N Papadopoulos J Jen SM Powel AJ Krush T Berk Z Cohen B Tetu, N Engl J Med 1995 332 839 847 10.1056/NEJM199503303321302 7661930
23. Multiple primary malignancies arising in the rectum, brain and thyroid. Report of a case. HW Crail, US Navy Med Bull 1949 49 123 128
24. Extra-intestinal manifestations of familial adenomatous polyposis. EJ Groen A Roos FL Muntinghe RH Enting J de Vries JH Kleibeuker MJ Witjes TP Links AP Van Beek, Ann Surg Oncol 2008 15 2439 2450 10.1245/s10434-008-9981-3 18612695
25. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. AL Knudsen ML Bisgaard S Bülow, Fam Cancer 2003 2 43 55 10.1023/A:1023286520725 14574166
26. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. ML Bisgaard K Fenger S Bülow E Niebuhr J Mohr, Hum Mutat 1994 3 121 125 10.1002/humu.1380030206 8199592
27. Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features. P Rozen Z Samuel M Rabau G Goldman R Shomrat C Legum A Orr-Urtreger, Fam Cancer 2001 1 75 82 10.1023/A:1013888226756 14574001
28. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). S Aretz D Stienen N Friedrichs S Stemmler S Uhlhaas N Rahner P Propping W Friedl, Hum Mutat 2007 28 985 992 10.1002/humu.20549 17486639
29. Identification and characterization of the familial adenomatous polyposis coli gene. J Groden A Thliveris W Samowitz M Carlson L Gelbert H Albertsen G Joslyn J Stevens L Spirio M Robertson, Cell 1991 66 589 600 10.1016/0092- 8674(81)90021-0 1651174
30. APC mutations occur early during colorectal tumorigenesis. SM Powell N Zilz Y Beazer-Barclay TM Bryan SR Hamilton SN Thibodeau B Vogelstein KW Kinzler, Nature 1992 359 235 237 10.1038/359235a0 1528264
31. APC mice: models, modifiers and mutants. AE McCart NK Vickaryous A Silver, Pathol Res Pract 2008 204 479 490 10.1016/j.prp.2008.03.004 18538487
32. Biology of the adenomatous polyposis coli tumor suppressor. KH Goss J Groden, Oncology 2000 18 1967 1979
33. The mutation spectrum of the APC gene in FAP patients from southern Italy: Detection of known and four novel mutations. M De Rosa Mi Scarano L Panariello G Morelli G Riegler GB Rossi A Tempesta G Romano A Renda G Pettinato P Izzo, Hum Mutat 2003 21 655 656 10.1002/humu.9151 14961559
34. Detecting mutations in the APC gene in familial adenomatous polyposis (FAP). MR Hegde BB Roa, Curr Protoc Hum Genet 2006 Chapter 10 Unit 10.8 18428386
35. Genetic testing for high-risk colon cancer patients. WM Grady, Gastroenterology 2003 124 1574 1594 10.1016/S0016-5085(03)00376-7 12761718
36. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. I Nishisho Y Nakamura Y Miyoshi Y Miki H Ando A Horii K Koyama J Utsunomiya S Baba P Hedge, Science 1991 253 665 669 10.1126/science.1651563 1651563 (Pubitemid 21917200)
37. Genotypephenotype correlation between position of constitutional APC gene mutation and CHRPE expression in FAP. YL Wallis F Macdonald M Hultén JEV Morton CM McKeown JP Neoptolemos M Keighley G Dion, Hum Genet 1994 5 543 548
38. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. ML Bisgaard S Bülow, Am J Med Genet 2006 140A 200 204 10.1002/ajmg.a.31010 (Pubitemid 43190928)
39. Screening for an inherited susceptibility to colorectal cancer. PT Rowley, Genet Test 2004 8 421 430 10.1089/gte.2004.8.421 15684875
40. Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. N Gavert T Naiman D Bercovich P Rozen R Shomrat C Legum A Orr-Urtreger, Hum Mutat 2002 19 64 66 10.1002/humu.9037
41. UBE3A mutation analysis by DHPLC. D Bercovich AL Beaudet, Genetic Testing 2003 7 189 194 10.1089/109065703322537197 14641994
42. Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. E Castellsagué S Gonzlez M Nadal O Campos E Guiná M Urioste I Blanco T Frebourg G Capell Clin Chem 2008 54 1132 1140 10.1373/clinchem.2007.101006 18487285
43. MutYH (MYH) and colorectal cancer. JR Sampson S Jones S Dolwani JP Cheadle, Biochem Soc Trans 2005 33 679 683 10.1042/BST0330679 16042573
44. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. S Aretz S Uhlhaas H Goergens K Siberg M Vogel C Pagenstecher E Mangold R Caspari P Propping W Friedl, Int J Cancer 2006 15;119 807 814 10.1002/ijc.21905 (Pubitemid 44051443)
45. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. MA Jenkins ME Croitoru N Monga SP Cleary M Cotterchio JL Hopper S Gallinger, Cancer Epidemiol Biomarkers Prev 2006 15 312 314 10.1158/1055-9965.EPI-05-0793 16492921
46. Similar colorectal cancer risk in patients with monoallelic and biallelic mutations in the MYH gene identified in a population with adenomatous polyposis. S Olschwang H Blanché C de Moncuit G Thomas, Genet Test 2007 11 315 320 10.1089/gte.2007.9995 17949294
47. Differential subcellular localization of human MutY homolog (hMYH) and the functional activity of adenine:8-oxoguanine DNA glycosylase. M Takao QM Zhang S Yonei A Yasui, Nucleic Acids Research 1999 27 3638 3644 10.1093/nar/27.18.3638 10471731
48. Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. T Ohtsubo K Nishioka Y Imaiso S Iwai H Shimokawa H Oda T Fujiwara Y Nakabeppu, Nucleic Acids Research 2000 28 1355 1364 10.1093/nar/28.6.1355 10684930
49. Genetic alterations of the MYH gene in gastric cancer. CJ Kim YG Cho CH Park SY Kim SW Nam SH Lee NJ Yoo JY Lee WS Park, Oncogene 2004 23 6820 6822 10.1038/sj.onc.1207574 15273732
50. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. OM Sieber L Lipton M Crabtree K Heinimann P Fidalgo RKS Phillips M-L Bisgaard TF Orntoft LA Aaltonen SV Hodgson HJW Thomas IPM Tomlinson, N Engl Med 2003 348 791 799 10.1056/NEJMoa025283 (Pubitemid 36245755)
51. Inherited variants of MYH associated with somatic G:C-T:A mutations in colorectal tumors. N Al-Tassan NH Chmiel J Maynard N Fleming AL Livingston GT Williams AK Hodges DR Davies SS David JR Sampson JP Cheadle, Nat Genet 2002 30 227 232 10.1038/ng828 11818965
52. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. V Gismondi M Meta L Bonelli P Radice P Sala L Bertario A Viel M Fornasarig A Arrigoni M Gentile M Ponz de Leon L Anselmi C Mareni P Bruzzi L Varesco, Int J Cancer 2004 109 680 684 10.1002/ijc.20054 14999774
53. A kindred with MYH-associated polyposis and pilomatricomas. S Baglioni G Melean F Gensini M Santucci M Scatizzi L Papi M Genuardi, Am J Med Genet 2005 134A 212 4 10.1002/ajmg.a.30585 15690400
54. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. KS Boparai E Dekker S Van Eeden MM Polak JFWM Bartelsman EMH Mathus-Vliegen JJ Keller CJM Van Noesel, Gastroenterology 2008 135 2014 2018 10.1053/j.gastro.2008.09.020 19013464
55. Molecular epidemiological analysis of the changing nature of a meningococcal outbreak following a vaccination campaign. L Shlush M Doron DM Behar Z Adrian K Nathy JR Lupski AL Beaudet D Bercovich, JCM 2002 40 3565 3571
56. Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. E Castellsagué S Gonzlez M Nadal O Campos E Guiná M Urioste I Blanco T Frebourg G Capell Clin Chem 2008 54 1132 1140 10.1373/clinchem.2007.101006 18487285
57. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. HT Lynch JF Lynch PM Lynch T Attard, Fam Cancer 2008 7 27 39 10.1007/s10689-007-9165-5 17999161
58. Testing children for cancer genes: the rule of earliest onset. ED Kodish, J Pediatr 1999 135 390 95 10.1016/S0022-3476(99)70142-3 10484811
59. Intention to learn results of genetic testing for hereditary colon cancer. SW Vernon ER Gritz SK Peterson CA Perz S Marani CI Amos WF Baile, Cancer Epidemiol Biomark Prev 1999 8 4 Pt 2 353 60
60. Transmitting genetic risk information in families: attitudes about disclosing the identity of relatives. JTR Wilcke N Seersholm A Kok-Jensen A Dirksen, Am J Hum Genet 1999 65 902 9 10.1086/302531 10441594
61. A survey of medical directors of life insurance companies concerning use of genetic information. JE McEwen K McCarty PR Reilly, Am J Hum Genet 1993 53 33 45 8317496
62. Health, life and disability insurance and hereditary nonpolyposis colorectal cancer. M Rodriguez-Bigas HFA Vasen L O'Malley MJ Rosenblatt C Farrell TK Weber NJ Petrelli, Am J Hum Genet 1998 62 736 37 10.1086/301753 9497250
63. Jurisprudential considerations in the evaluation and screening of high-risk patients. PM Lynch, Secondary Prevention of Colorectal Cancer Karger: Basel, Rozen P, Winawer SJ, 1986 55 63
64. Attitudes to predictive DNA testing in familial adenomatous polyposis. S Whitelaw JM Northover SV Hodgson, J Med Genet 1996 33 540 543 10.1136/jmg.33.7.540 8818937
65. Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. F Kastrinos EM Stoffel J Balmãa S Syngal, Am J Gastroenterol 2007 102 1284 1290 10.1111/j.1572-0241.2007.01168.x 17355417
66. Impact of familial adenomatous polyposis on young adults: attitudes toward genetic testing, support, and information needs. L Andrews S Mireskandari J Jessen B Thewes M Solomon F Macrae B Meiser, Genet Med 2006 8 697 703 17108761
67. CDC published report on chorionic villous sampling and amniocentesis. Am Fam Physician 1995 52 1210 7668210
68. Strategies and outcomes of PGD of familial adenomatous polyposis. C Moutou N Gardes JC Nicod S Viville, Mol Hum Reprod 2007 13 95 101 10.1093/molehr/gal102 17114207
69. Preimplantation genetic diagnosis of familial adenomatous polyposis. T Davis B Song DS Cram, Reprod Biomed Online 2006 13 707 711 17169185
70. Who are at risk for familial colorectal cancer and how can they be managed? P Rozen B Levin GP Young, Colorectal Cancer in Clinical Practice: Prevention, Early Detection and Management London, Taylor and Francis, Rozen P, Young GP, Levin B, Spann SJ, 2 2002 55 66
71. Guidelines for the clinical management of familial adenomatous polyposis (FAP). HF Vasen G Möslein A Alonso S Aretz I Bernstein L Bertario I Blanco S Bülow J Burn G Capella C Colas C Engel I Frayling W Friedl FJ Hes S Hodgson H Järvinen JP Mecklin P Møller T Myrhøi FM Nagengast Y Parc R Phillips SK Clark MP de Leon L Renkonen-Sinisalo JR Sampson A Stormorken S Tejpar HJ Thomas J Wijnen, Gut 2008 57 704 713 10.1136/gut.2007. 136127 18194984
72. Familial colorectal cancer. RW Burt GM Peterson, Prevention and Early Detection of Colorectal Cancer London, Saunders, Young GP, Rozen P, Levin B, 1996 171 94
73. An unusually severe phenotype for familial adenomatous polyposis. DM Eccles PW Lunt Y Wallis M Griffiths B Sandhu S Mckay D Morton J Shea-Simonds F Macdonald, Arch Dis Child 1997 77 431 435 10.1136/adc.77.5.431 9487968
74. Can we safely delay or avoid prophylactic colectomy in familial adenomatous polyposis? RKS Phillips AD Spigelman, Br J Sur 1996 83 769 770 10.1002/bjs.1800830613 (Pubitemid 26000060)
75. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. O Aziz T Athanasiou VW Fazio RJ Nicholls AW Darzi J Church RK Phillips PP Tekkis, Br J Surg 2006 93 407 417 10.1002/bjs.5276 16511903
76. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. C Bülow H Vasen H Jarvinen J Bjork ML Bisgaard S Bülow, Gastroenterology 2000 119 1454 1460 10.1053/gast.2000. 20180 11113066
77. Results after restorative proctocolectomy and ileal pouch anal anastomosis in patients with familial adenomatous polyposis and coexisting colorectal cancer. Y Ziv JM Church JR Oakley E McGannon TK Schroeder VF Fazio, Br J Surg 1996 83 1578 1580 10.1002/bjs.1800831128 9014679
78. Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis (Review). P Setti-Carraro RJ Nicholls, Br J Surg 1996 83 885 892 10.1002/bjs.1800830704 8813770
79. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis. A ten years experience. A Kartheuser R Parc C Penna E Tiret P Frileux L Hannoun B Nordlinger J Loygue, Surgery 1996 119 615 23 10.1016/S0039-6060(96)80185-1 8650601
80. Familial adenomatous polyposis: Prevalence of adenomas in the ileal pouch after restorative proctocolectomy. YR Parc S Olschwang B Desaint G Schmitt RG Parc E Tiret, Ann Surg 2001 233 360 364 10.1097/00000658-200103000-00009 11224623
81. Female fecundity before and after operation for familial adenomatous polyposis. K Olsen S Juul S Bülow HJ Järvinen A Bakka J Björk T Oresland S Laurberg, Br J Surg 2003 90 227 231 10.1002/bjs.4082 12555301
82. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. A Kartheuser P Stangherlin D Brandt C Remue C Sempoux, Fam Cancer 2006 5 241 260 10.1007/s10689-005-5672-4 16998670
83. Endoscopic surveillance of the ileoanal pouch following restorative proctocolectomy for familial adenomatous polyposis. DP Hurlstone BP Saunders JM Church, Endoscopy 2008 40 437 42 10.1055/s-2007-995655 18398783
84. Anal transitional zone cancer after restorative proctocolectomy and ileoanal anastomosis in familial adenomatous polyposis: report of two cases. BS Ooi FH Remzi T Gramlich JM Church M Preen VW Fazio, Dis Colon Rectum 2003 46 1418 1423 10.1007/s10350-004-6760-5 14530685
85. Familial adenomatous polyposis: The practical applications of clinical and molecular screening. P Rozen F Macrae, Fam Cancer 2006 5 227 235 10.1007/s10689-005-5674-2 16998668
86. Familial adenomatous polyposis. Results after ileal pouch-anal anastomosis in teenagers. Y Parc G Moslein RR Dozois JH Pemberton BG Wolff JE King, Dis Colon Rectum 2000 43 893 902 10.1007/BF02237346 10910233
87. Ileal pouch-anal anastomoses complications and function in 1005 patients. VW Fazio Y Ziv JM Church JR Oakley IC Lavery JW Milsom TK Schroeder, Ann Surg 1995 222 120 127 10.1097/00000658-199508000-00003 7639579
88. What functional outcomes and complications should be taught to the patient with ulcerative colitis or familial adenomatous polyposis who undergoes ileal pouch anal anastomosis. JC Colwell M Gray, J Wound Ostomy Continence Nurs 2001 28 184 189 11452254
89. Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results. DC Nyam PT Brillant RR Dozois KA Kelly JH Pemberton BG Wolff, Ann Surg 1997 226 514 519 10.1097/00000658-199710000-00012 9351719
90. Pancreas preserving duodenectomy in the management of duodenal familial adenomatous polyposis. MF Kalady BM Clary DS Tyler TN Pappas, J Gastrointest Surg 2002 6 82 87 10.1016/S1091-255X(01)00005-1 11986022
91. Is there an advantage in performing a pancreas-preserving total duodenectomy in duodenal adenomatosis? MW Müller R Dahmen J Köninger CW Michalski U Hinz M Hartel M Kadmon J Kleeff MW Büchler H Friess, Am J Surg 2008 195 741 748 10.1016/j.amjsurg.2007.08.061 18436175
92. Stepwise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring system. SB Middleton SK Clark P Matravers D Katz R Reznek RK Phillips, Dis Colon Rectum 2003 46 481 485 10.1007/s10350-004-6586-1 12682541
93. Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease. JM Church T Berk BM Boman J Guillem C Lynch P Lynch M Rodriguez-Bigas L Rusin T Weber Collaborative Group of the Americas on Inherited Colorectal Cancer, Dis Colon Rectum 2005 48 1528 1534 10.1007/s10350-005-0018-8 15906134
94. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. A Hansmann C Adolph T Vogel A Unger G Moeslein, Cancer 2004 100 612 620 10.1002/cncr.11937 14745880
95. The efficacy of radiotherapy as postoperative treatment for desmoid tumors. JA Jelinek KJ Stelzer E Conrad J Bruckner M Kliot W Koh GE Laramore, Int J Radiat Oncol Biol Phys 2001 50 121 125 11316554
96. Multimodality treatment of mesenteric desmoid tumours. MM Bertagnolli JA Morgan CD Fletcher CP Raut P Dileo RR Gill GD Demetri S George, Eur J Cancer 2008 44 2404 2410 10.1016/j.ejca.2008.06.038 18706807
97. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. NA Abrahams A Halverson VW Fazio LA Rybicki JR Goldblum, Dis Colon Rectum 2002 45 1496 502 10.1007/s10350-004-6457-9 12432298
98. Video capsule endoscopy compared with standard endoscopy for the evaluation of small-bowel polyps in persons with familial adenomatous polyposis (with video). RF Wong AK Tuteja DS Haslem L Pappas A Szabo MM Ogara JA DiSario, Gastrointest Endosc 2006 64 530 537 10.1016/j.gie.2005.12.014 16996344
99. Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. F Maire P Hammel B Terris S Olschwang D O'Toole A Sauvanet L Palazzo P Ponsot B Laplane P Lévy P Ruszniewski, Gut 2002 51 446 449 10.1136/gut.51.3.446 12171972
100. MR appearances of desmoid tumors in familial adenomatous polyposis. JC Healy RH Reznek SK Clark RK Phillips P Armstrong, Am J Roentgenol 1997 169 465 472
101. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001 121 195 197 10.1053/gast.2001.25580 11438508
102. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in APC (Min) mice through different mechanisms. V Mai LH Colbert D Berrigan SN Perkins R Pfeiffer JA Lavigne E Lanza DC Haines A Schatzkin SD Hursting, Cancer Res 2003 63 1752 1755 12702556
103. Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. RF Jacoby CE Cole ET Hawk RA Lubet, Gastroenterology 2004 127 838 44 10.1053/j.gastro.2004.06.003 15362039
104. Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9. P Rozen Z Samuel R Shomrat C Legum, Gut 1999 45 829 33 10562580
105. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. M Cruz-Correa LM Hylind KE Romans SV Booker FM Giardiello, Gastroenterology 2002 122 641 645 10.1053/gast.2002.31890 11874996
106. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. FM Giardiello SR Hamilton AJ Krush S Piantadosi LM Hylind P Celano SV Booker CR Robinson GJ Offerhaus, N Engl J Med 1993 328 1313 1316 10.1056/NEJM199305063281805 8385741
107. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. G Steinbach PM Lynch RK Phillips MH Wallace E Hawk GB Gordon N Wakabayashi B Saunders Y Shen T Fujimura LK Su B Levin, N Engl J Med 2000 342 1946 1952 10.1056/NEJM200006293422603 10874062
108. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. T Higuchi T Iwama K Yoshinaga M Toyooka MM Taketo K Sugihara, Clin Cancer Res 2003 9 4756 4760 14581346
109. Rofecoxib reduces polyp recurrence in familial polyposis. A Hallak L Alon-Baron R Shamir M Moshkowitz B Bulvik E Brazowski Z Halpern N Arber, Dig Dis Sci 2003 48 1998 2002 10.1023/A:1026130623186 14627347
110. European Medicines Agency Doc.Ref.:EMEA/COMP/91/02Rev.2. http://www.emea.europa.eu/pdfs/human/comp/opinion/009102en.pdf
111. Primary chemoprevention of familial adenomatous polyposis with sulindac. FM Giardiello VW Yang LM Hylind AJ Krush GM Petersen JD Trimbath S Piantadosi E Garrett DE Geiman W Hubbard GJ Offerhaus SR Hamilton, N Engl J Med 2002 346 1054 1059 10.1056/NEJMoa012015 11932472
112. Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. RS Bresalier RS Sandler H Quan JA Bolognese B Oxenius K Horgan C Lines R Riddell D Morton A Lanas MA Konstam JA Baron, N Engl J Med 2005 352 1092 1102 10.1056/NEJMoa050493 15713943
113. Association between Cyclooxygenase expression and colorectal adenoma characteristics. JG Einspahr RS Krouse JM Yochim PV Danenberg KD Danenberg AK Bhattacharyya ME Martínez DS Alberts, Cancer Res 2003 63 3891 3893 12873979
114. Oral contraceptives and polyp regression in familial adenomatous polyposis. FM Giardiello LM Hylind JD Trimbath SR Hamilton KE Romans M Cruz-Correa MC Corretti GJ Offerhaus VW Yang, Gastroenterology 2005 128 1077 1080 10.1053/j.gastro.2004.10.010 15825088